跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAYZENT siponimod 2 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MAYZENT siponimod 2 mg film-coated tablet blister pack
Approved
STANDARD
MAYZENT siponimod 2 mg film-coated tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c7bd37f14857a8f9
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c7bd37f14857a8f9
Product Name
MAYZENT siponimod 2 mg film-coated tablet blister pack
Artg Id
310499
Artg Name
MAYZENT siponimod 2 mg film-coated tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2019-11-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/aac69f760c6d3d9405c124af57913b97.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/cc9c2d43283cafe47db64178628901eb.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c7bd37f14857a8f9
Type
Standard
Back to TGA Approvals
